Figure 3.
Overall survival by FLT3-ITD length at baseline. (A) Impact of FLT3-ITD length relative to median value: ≤51 bp vs >51 bp. (B) Relative impact of FLT3-ITD length and multiple FLT3-ITD mutations in the gilteritinib arm. (C) Relative impact of FLT3-ITD length and multiple FLT3-ITD mutations in the salvage chemotherapy arm.

Overall survival by FLT3-ITD length at baseline. (A) Impact of FLT3-ITD length relative to median value: ≤51 bp vs >51 bp. (B) Relative impact of FLT3-ITD length and multiple FLT3-ITD mutations in the gilteritinib arm. (C) Relative impact of FLT3-ITD length and multiple FLT3-ITD mutations in the salvage chemotherapy arm.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal